Suppr超能文献

[术中放疗在子宫癌治疗中的作用。里昂的初步经验]

[Role of peroperative radiotherapy in the treatment of uterine cancers. Preliminary experience in Lyon].

作者信息

Gérard J P, Dargent D, Raudrant D, Braillon G, Gilly F N, Romestaing P, Sentenac I, Rocher F P, Berger C, Adeleine P

机构信息

Service de radiothérapie-oncologie, centre hospitalier Lyon Sud, Pierre-Bénite, France.

出版信息

Bull Cancer Radiother. 1994;81(3):186-95.

PMID:7702902
Abstract

AIM

Retrospective analysis of Intra operative Radiotherapy (IORT) in recurrent uterine carcinoma (RUC) and prospective pilot study of IORT in advanced cervix cancer (ACC) with high risk of local failure. PATIENTS-TREATMENTS: 1) RUC: from 1988 to 1991, 34 patients with RUC have been treated. Primary cancer was: cervix uterus: 28, endometrium: six. Site of recurrence: centro pelvis: four, latero pelvis: 25, lombo aortic: five. Total gross resection was only possible in 12 patients. A dose of 15 to 22 Gy was given by IORT according to the residual tumour size. External beam irradiation was added in 16 patients; 2) ACC: January 1991 to November 1992, 20 patients were included in this pilot study, stage IIB: seven, stage III: 12, stage IV: 1. Preoperative retroperitoneal pelviscopy showed 13 pN1 patients and NMR imaging ten tumours of 6 cm or larger in diameter. Treatment started with concommitant pelvic irradiation (44 Gy) and one conommitant cycle of 5 Fu-CDDP, followed by a short course of high dose rate upper vagina brachytherapy (4 Gy). Four weeks later a radical Wertheim operation was performed together with IORT on the lateral pelvis.

RESULTS

  1. RUC: overall survival (Kaplan Meier) at 4 years is 32% (+/- 8). Local relapse in the fiedl of IORT was observed in six patients. Grade 2-3 complications: six patients (radiation proctitis, neuritis, vertebral collapse, ureteral stenosis); 2) ACC: the median follow up is hort (18 months). Four cases of pelvic relapse, no postoperative death. The first line radio chemotherapy was associated with two G3 early complications. Postoperative radiation complication was less than 10% G3.

DISCUSSION

promising results of IORT in RUC have been observed especially if no irradiation is given during the primary treatment. Good feasibility of the pilot study of IORT in ACC was also observed. It could be followed by a multicentric feasibility trial.

摘要

目的

对复发性子宫癌(RUC)术中放疗(IORT)进行回顾性分析,并对局部失败风险高的晚期宫颈癌(ACC)开展IORT前瞻性初步研究。患者-治疗情况:1)RUC:1988年至1991年,34例RUC患者接受了治疗。原发癌为:子宫颈癌28例,子宫内膜癌6例。复发部位:盆腔中央4例,盆腔侧壁25例,腰主动脉旁5例。仅12例患者实现了肿瘤全切。根据残留肿瘤大小,IORT给予的剂量为15至22 Gy。16例患者加用了外照射;2)ACC:1991年1月至1992年11月,20例患者纳入该初步研究,IIB期7例,III期12例,IV期1例。术前腹膜后盆腔镜检查显示13例患者有盆腔淋巴结转移(pN1),核磁共振成像显示10个肿瘤直径≥6 cm。治疗开始时同步进行盆腔照射(44 Gy)和1个周期的5-氟尿嘧啶-顺铂同步化疗,随后进行短疗程高剂量率阴道上段近距离放疗(4 Gy)。4周后进行根治性韦特海姆手术,并对盆腔侧壁进行IORT。

结果

1)RUC:4年总生存率(Kaplan-Meier法)为32%(±8)。6例患者在IORT照射野内出现局部复发。2-3级并发症:6例患者(放射性直肠炎、神经炎、椎体塌陷、输尿管狭窄);2)ACC:中位随访时间较短(18个月)。4例盆腔复发,无术后死亡。一线放化疗出现2例3级早期并发症。术后放疗并发症3级低于1%。

讨论

观察到IORT在RUC中取得了有前景的结果,尤其是在原发治疗期间未进行放疗的情况下。IORT在ACC初步研究中的可行性良好。后续可开展多中心可行性试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验